Clinical trial
Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD…
NCT00402298 · Lykos Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00402298 |
|---|---|
| Title | Randomized Placebo-controlled Study of MDMA-assisted Therapy in People With PTSD - Israel |
| Official title | MDMA-assisted Therapy in Twelve People With War and Terrorism-related Posttraumatic Stress Disorder (PTSD) |
| Lead sponsor | Lykos Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | Full Dose Midomafetamine HCl, Low Dose Midomafetamine HCl |
| Enrollment | 5 |
| Start date | May 27, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | May 5, 2010 |
| First posted | Nov 22, 2006 |
| Last update posted | Jun 5, 2025 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: